Mon Aug 23, 2021 – 12:58 pm EDTMon Aug 23, 2021 – 1:03 pm EDT
WASHINGTON, D.C. (LifeSiteNews) – The U.S. Food and Drug Administration (FDA) has given its full approval to the abortion-tainted Pfizer/BioNTech COVID-19 vaccine, the first to receive the agency’s full approval.
The full permission, described by the agency as a “key achievement for public health,” comes despite the National Institutes for Health (NIH) estimating a trial completion date for testing the efficacy and safety of the jab to be around May 2, 2023, for the Pfizer shot.
The FDA had originally granted the mRNA jab emergency use authorization (EUA) in December, 2020, becoming the second “vaccine” technology of its kind to be permitted for emergency use in the U.S., after Moderna’s mRNA shot.
Now, the FDA has given its full approval to the jab, which has been renamed “Comirnaty” for marketing purposes, to individuals aged 16 and older. For those between 12 and 15 years of age, the EUA still applies. The FDA noted that “the administration of a third dose in certain immunocompromised individuals” will also still only be granted under the EUA protocol.
The FDA’s Acting Commissioner, Janet Woodcock, called
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors